Clovis Oncology Inc (CLVS) Return on Assets ROA from the third quarter of 2022 to third quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Clovis Oncology inc   (NASDAQ: CLVS)


Clovis Oncology Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Clovis Oncology Inc 's ROA in the third quarter of 2022?
Clovis Oncology Inc recorded a cumulative net loss of $-252 million during 12 months ending in the third quarter of 2022, resulting in a negative return on assets (ROA) of -63.11%.

However, within the Healthcare sector 851 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2022 quarter, so far to 5011, from total ROA ranking in the second quarter of 2022 at 5103.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Total Assets Change -32.16 % -31.84 % -16.46 % -21.27 % -13.25 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -252 -263 -258 -265 -299
Return On Assets (TTM) -63.11 % -60.05 % -53.57 % -52.5 % -55.96 %
CLVS's Total Ranking # 5011 # 5103 # 4992 # 5317 # 4434
Total Assets (TTM) in million 331 376 435 454 489
Seq. Total Assets Change -11.94 % -13.39 % -4.29 % -7.07 % -11.53 %
Seq. Net Income Change - - - - -

CLVS's 5 Years Annual ROA >> Back to CLVS Management Effectiveness >> Compare CLVS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 399
Sector # 852
Overall # 4907

Return On Assets Statistics
High Average Low
-9.27 %
-44.79 %
-74.45 %
(Sep 30 2013)   (Dec 31 2016)





Financial Statements
Clovis Oncology Inc 's Assets $ 331 million CLVS's Balance sheet
Clovis Oncology Inc 's Income $ -56 million Quarterly CLVS's Income Statement
CLVS's Income by Division See CLVS's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017
Y / Y Total Assets Change -21.27 % -13.87 % -22.46 % 17.45 % 101.68 %
Total Assets in million 454 577 670 864 735
Y / Y Net Income Change - - - - -
Net Income in million -265 -369 -400 -368 -346
Annual Return On Assets -58.25 % -64.02 % -59.8 % -42.62 % -47.11 %

CLVS's 5 Years Annual ROA >> Back to CLVS Management Effectiveness >> Compare CLVS ROA to its Competitors



More Return On Assets Ratios
CLVS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CLVS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CLVS's Competitors
Subscribers only: Roa for Clovis Oncology Inc 's Suppliers
Subscribers only: Return On Assets for CLVS's Customers

You may also want to know
CLVS's Roi CLVS's Inventory Turnover Ratio CLVS's Growth Rates CLVS's Dividend Comparisons
CLVS's Profitability Ratios CLVS's Asset Turnover Ratio CLVS's Dividend Growth
CLVS's Roe CLVS's Valuation Ratios CLVS's Financial Strength Ratios CLVS's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:46+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.